Study of TG-1801 in Subjects With B-Cell Lymphoma

Clinical trial NCT03804996 · COMPLETED

Trial details

NCT number: NCT03804996
Sponsor: TG Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Lymphoma

Start date: 2019-03-05
Primary completion: 2024-02-21
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.